Kiyoshi Takayama (President, NBHL) will give a presentation at Antibody Engineering & Therapeutics 2019 to be held in San Diego, USA, from December 9th to 13th, 2019. His talk will focus on the innovative high-throughput single-cell technology RiGRASS^TM for the discovery of functional anti-GPCR antibodies.

 [Date of Presentation]

 December 11th, 2019 (2:55 pm – 3:25 pm)

 [Venue]

 Marriott Marquis San Diego

 [Session]

 Track 1: Emerging Technologies and Approaches for Antibody Engineering

 [Presentation Title]

 Discovery of Therapeutic Functional mAbs Targeting GPCR with a Unique Single Cell Analysis Technique

 [URL]

 https://lifesciences.knect365.com/antibody-engineering-therapeutics/